Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-25-000542
Filing Date
2025-02-19
Accepted
2025-02-19 07:00:22
Documents
3
Period of Report
2025-02-19

Document Format Files

Seq Description Document Type Size
1 6-K zk2532752.htm 6-K 10384
2 EXHIBIT 99.1 exhibit_99-1.htm EX-99.1 24032
3 image00004.jpg GRAPHIC 4120
  Complete submission text file 0001178913-25-000542.txt   41449
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

EIN.: 813676773 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38807 | Film No.: 25637147
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)